Skip to main content
logo
Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
6.48
-0.06 (-0.92%)
At close: Sep 8, 2026, 4:00 PM EDT
6.48
-0.06 (-0.92%)
Pre-market: Sep 9, 2026, 5:37 AM EDT

Anbio Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2841,320----
Market Cap Growth
-86.29%-----
Enterprise Value
2731,306----
Last Close Price
6.4830.07----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
44.19206.11----
PS Ratio
32.89152.64----
PB Ratio
9.4343.77----
P/TBV Ratio
9.4343.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
31.52151.08----
EV/EBIT Ratio
47.25226.50----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.39-0.39-0.68-0.65-0.69-1.65
Asset Turnover
0.350.350.470.452.50-
Quick Ratio
177.13177.137.4111.656.142.06
Current Ratio
344.31344.3110.7115.869.882.07
Return on Equity (ROE)
27.05%27.05%14.83%16.47%132.75%-
Return on Assets (ROA)
14.66%14.66%7.18%8.23%67.52%-
Return on Capital Employed (ROCE)
19.10%19.10%11.60%13.20%81.30%96.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.25%0.48%----
Buyback Yield / Dilution
-3.26%-3.26%-97.30%---
SEC Filings: 10-K · 10-Q